CP1 injection enhanced the immunogenic cell death of cancer cells, boosted T cell cytotoxicity, and promoted the infiltration of activated CD8+ T cells as well as other cell types such as NK cells, M1 macrophages, and mature dendritic cells into the tumor. The gene discussed is CD8A; the disease is cancer.